153 related articles for article (PubMed ID: 19501156)
1. Green tea EGCG suppresses T cell proliferation through impairment of IL-2/IL-2 receptor signaling.
Wu D; Guo Z; Ren Z; Guo W; Meydani SN
Free Radic Biol Med; 2009 Sep; 47(5):636-43. PubMed ID: 19501156
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin-3-gallate directly suppresses T cell proliferation through impaired IL-2 utilization and cell cycle progression.
Pae M; Ren Z; Meydani M; Shang F; Meydani SN; Wu D
J Nutr; 2010 Aug; 140(8):1509-15. PubMed ID: 20534878
[TBL] [Abstract][Full Text] [Related]
3. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases.
Wu D; Wang J; Pae M; Meydani SN
Mol Aspects Med; 2012 Feb; 33(1):107-18. PubMed ID: 22020144
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin-3-gallate inhibits expression of receptors for T cell regulatory cytokines and their downstream signaling in mouse CD4+ T cells.
Wang J; Pae M; Meydani SN; Wu D
J Nutr; 2012 Mar; 142(3):566-71. PubMed ID: 22323768
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of beta-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H(2)O(2) at physiologically relevant EGCG concentrations.
Dashwood WM; Orner GA; Dashwood RH
Biochem Biophys Res Commun; 2002 Aug; 296(3):584-8. PubMed ID: 12176021
[TBL] [Abstract][Full Text] [Related]
6. Green tea EGCG, T-cell function, and T-cell-mediated autoimmune encephalomyelitis.
Wu D
J Investig Med; 2016 Dec; 64(8):1213-1219. PubMed ID: 27531904
[TBL] [Abstract][Full Text] [Related]
7. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
8. Effect of black and green tea polyphenols on c-jun phosphorylation and H(2)O(2) production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction.
Yang GY; Liao J; Li C; Chung J; Yurkow EJ; Ho CT; Yang CS
Carcinogenesis; 2000 Nov; 21(11):2035-9. PubMed ID: 11062165
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-Gallate (EGCG), an Active Compound of Green Tea Attenuates Acute Lung Injury Regulating Macrophage Polarization and Krüpple-Like-Factor 4 (KLF4) Expression.
Almatroodi SA; Almatroudi A; Alsahli MA; Aljasir MA; Syed MA; Rahmani AH
Molecules; 2020 Jun; 25(12):. PubMed ID: 32575718
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-kappaB.
Ahn SC; Kim GY; Kim JH; Baik SW; Han MK; Lee HJ; Moon DO; Lee CM; Kang JH; Kim BH; Oh YH; Park YM
Biochem Biophys Res Commun; 2004 Jan; 313(1):148-55. PubMed ID: 14672711
[TBL] [Abstract][Full Text] [Related]
11. Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF-β- induced Epithelial-to-mesenchymal transition via ROS/Smad signaling in human cervical cancer cells.
Panji M; Behmard V; Zare Z; Malekpour M; Nejadbiglari H; Yavari S; Nayerpour Dizaj T; Safaeian A; Maleki N; Abbasi M; Abazari O; Shabanzadeh M; Khanicheragh P
Gene; 2021 Aug; 794():145774. PubMed ID: 34126197
[TBL] [Abstract][Full Text] [Related]
12. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells.
Ahmad N; Gupta S; Mukhtar H
Arch Biochem Biophys; 2000 Apr; 376(2):338-46. PubMed ID: 10775421
[TBL] [Abstract][Full Text] [Related]
13. Hibernation, reversible cell growth inhibition by epigallocatechin-3-O-gallate.
Matsumura K; Kim JY; Tsutsumi S; Hyon SH
J Biotechnol; 2007 Jan; 127(4):758-64. PubMed ID: 16996160
[TBL] [Abstract][Full Text] [Related]
14. (-)-Epigallocatechin-3-gallate blocks 3T3-L1 adipose conversion by inhibition of cell proliferation and suppression of adipose phenotype expression.
Chan CY; Wei L; Castro-Muñozledo F; Koo WL
Life Sci; 2011 Nov; 89(21-22):779-85. PubMed ID: 21978785
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of green tea polyphenol EGCG((-)-epigallocatechin-3-gallate) on the proliferation of gastric cancer cells by suppressing canonical wnt/β-catenin signalling pathway.
Yang C; Du W; Yang D
Int J Food Sci Nutr; 2016 Nov; 67(7):818-27. PubMed ID: 27338284
[TBL] [Abstract][Full Text] [Related]
16. Green tea polyphenol epigallocatechin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathway.
Park G; Yoon BS; Moon JH; Kim B; Jun EK; Oh S; Kim H; Song HJ; Noh JY; Oh C; You S
J Invest Dermatol; 2008 Oct; 128(10):2429-41. PubMed ID: 18463684
[TBL] [Abstract][Full Text] [Related]
17. Immune cell activation and subsequent epithelial dysfunction by Staphylococcus enterotoxin B is attenuated by the green tea polyphenol (-)-epigallocatechin gallate.
Watson JL; Vicario M; Wang A; Moreto M; McKay DM
Cell Immunol; 2005 Sep; 237(1):7-16. PubMed ID: 16213476
[TBL] [Abstract][Full Text] [Related]
18. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.
Xu H; Becker CM; Lui WT; Chu CY; Davis TN; Kung AL; Birsner AE; D'Amato RJ; Wai Man GC; Wang CC
Fertil Steril; 2011 Oct; 96(4):1021-8. PubMed ID: 21821246
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of green tea catechins on cell growth and apoptosis induction in gastric carcinoma cells.
Horie N; Hirabayashi N; Takahashi Y; Miyauchi Y; Taguchi H; Takeishi K
Biol Pharm Bull; 2005 Apr; 28(4):574-9. PubMed ID: 15802789
[TBL] [Abstract][Full Text] [Related]
20. Roles of catalase and hydrogen peroxide in green tea polyphenol-induced chemopreventive effects.
Yamamoto T; Lewis J; Wataha J; Dickinson D; Singh B; Bollag WB; Ueta E; Osaki T; Athar M; Schuster G; Hsu S
J Pharmacol Exp Ther; 2004 Jan; 308(1):317-23. PubMed ID: 14569057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
